References
- Abdulazeez, M. (2011). Effect of Peristrophe bicalyculata on lipid profile of P- 407-induced hyperlipidemic Wistar rats. J. of Med. Plants Res., 5(4), 490-494.
- Akoh, C.C. (2005). Handbook of Functional Lipids. Boca Raton, FL: CRC Press.
- Baum, J.A., Teng, H., Erdman, J.W., Weigel, R.M., Klein, B.P., Persky, V.W., Freels, S., Surya, P., Bakhit, R.M., Ramos, E., Shay, N.F., & Potter, S.M. (1998). Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. American J. of Clin. Nutr., 68(3), 545-551. https://doi.org/10.1093/ajcn/68.3.545
- Beckmann, N., Cannet, C., Babib, A.L., Bie, F.X., Zurbruegg, S., Kneuer, R., & Dousset, V. (2009). In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging. Nanomed. and Nanobiotech, 1(3), 272-298. https://doi.org/10.1002/wnan.16
- Brown, S.L. (1996). Lowered serum cholesterol and low mood. Brit. J. of med, 313, 637-638. https://doi.org/10.1136/bmj.313.7058.637
- Davey, S.G. (1993). Cholesterol lowering and mortality: the importance of considering initial level of risk. Int. Med. J., 306, 1367-1373.
- Davey, S.G., & Pekkanen, J. (1992). Should there be a moratorium on the use of cholesterol lowering drugs? Br. Med J., 304, 431-440. https://doi.org/10.1136/bmj.304.6824.431
- Dobiasova, M. (2006). AIP-atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitrni Lekarstvi, 52(1), 64-71.
- Dobiasova, M., & Frohlich, J. (2001). The plasma parameter Log (TG/HDLC) as an atherogenic index: correlation with lipoprotein particle size and etherification rate in apoB-lipoprotein-depleted plasma (FERHDL). J. of Clin. Biochem., 12, 588-592.
- Dobiavosa, M., Urbanova, Z., & Samanek, M. (2005). Relation between particle size of HDL and LDL Lipoproteins and cholesterol Esterification rate. Physiol. Res., 54, 159-165.
- Duke, J.A. (1993). Medicinal plants and the pharmaceutical industry. In J. Janick & J.E. Simon, New Crops (pp. 664-669). Wiley, NY: John Wiley & Sons Ltd.
- Dumortier, G., Grossiord, J.L., Agnely, F., & Chaumeil, J.C. (2006). A review of poloxamer 407 pharmaceutical and pharmacological Characteristics. Pharmace. Res., 23(12), 2709-2728. https://doi.org/10.1007/s11095-006-9104-4
- F.A.O. (1983). Food and fruit bearing forest species: Examples from Eastern Africa.
- Friedewald, W.T. (1972). Methods for the determination of LDL Cholesterol. Clin. Chem., 18, 499-502.
- Geetha, G., Kalavalarasariel, G.P., & Sankar, V. (2011). Antidiabetic effect of Achyranthesrubrofusca leaf extracts on alloxan induced diabetic rats. Pak J. of Pharmace. Sci., 24(2), 193-199.
- Grundy, S.M. (1986). Cholesterol and coronary heart disease: a new era. J.Am. Med. Assoc., 256, 2849-2858. https://doi.org/10.1001/jama.1986.03380200087027
- Johnston, T.P. (2004). The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: A review of findings to date. J. Cardiovasc. Pharmacol., 43(4), 595-606. https://doi.org/10.1097/00005344-200404000-00016
- Johnston, T.P., Punjabiand, M.A., & Froelich, C.J. (1992). Sustained delivery of interleukin-2 from a poloxamer- 407 gel matrix following intraperitoneal injection in mice. Pharm. Res., 9, 425-434. https://doi.org/10.1023/A:1015815624334
- Kaesancini, A.Y., & Krauss, R.M. (1994). Cardio vascular disease and hyperlipidemia. Cur. Opinion in lipidolo., 5, 249-251. https://doi.org/10.1097/00041433-199408000-00001
- Karmarkar, B. (2008). Poloxamers and their applications. Pharmacy Student Articles. Retrieved 15 February, 2012 from http://www.pharmainfo.net.
- Kastelein, J.J.P., van der Steeg, W.A., Holme, L., Gaffney, M., CaterBarter, N.B., Deedwania, P., Olsson, A.G., Boekholdt, S.M., Demicco, D.A., Szarek, M., LaRosa, J.C., Pedersen, T.R., Grundy, S.M., & IDEAL study Groups. (2008). Lipids apolipoproteins and their ratios in relation to cardiovascular events with statin treatment. Circul. 117(23), 3002-3009 https://doi.org/10.1161/CIRCULATIONAHA.107.713438
- Kim, H., Jeong, D., Jung, H., Yokozawaand, T., & Choi, J. (2008). Hypolipidemic Effects of Sophoraflavescens and Its Constituents in Poloxamer 407- Induced Hyperlipidemic and Cholesterol-Fed Rats. Biolo. and Pharmace. Bulletin., 31(1), 73-78.
- Kumar, S., Kumar, R., & Khan, A. (2011). Medicinal Plant Resources: Manifestation and Prospects of Life sustaining Healthcare System. Conti. J. of Biolo. Sci., 4 (1), 19-29.
- Lorke, D. (1983). A new approach to practical acute toxicity testing. Archiv. of Toxicol., 54(4), 275-287. https://doi.org/10.1007/BF01234480
- Mahmood, Z.A., Mohammad, S., Mahmood, S.B.Z., & Karim, M.A. (2010). Herbal treatment for cardiovascular disease the evidence based therapy. Pak. J. of Pharmace. Sci., 23(1), 119-124.
- Megalli, S., Aktan, F., Daviesand, N.M., & Roufogalis, B.D. (2005). Phytopreventative anti-hyperlipidemic effects of Gynostemma pentaphyllum in rats. J. Pharm. Set., 8(3), 507-15.
- Messina, M.J. (1999). Legumes and soybeans: Overview of their nutritional profiles and health effects. Am. J. Clin. Nutr., 70(3), 439-450. https://doi.org/10.1093/ajcn/70.4.439
- Murphy, S.A., Cannon, C.P., & Braunwald, E. (2007). Effect of intensive lipid lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction (22 trials). The Ame. J. of Cardio., 100(7), 1047-1051. https://doi.org/10.1016/j.amjcard.2007.04.053
- Nicholls, S.J., Tuzcu, E.M., & Sipahi, I. (2007). Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. J. of the Ame. Med. Assoc., 297(5), 499-508. https://doi.org/10.1001/jama.297.5.499
- Nissen, S.E., Tuzcu, E.M., & Brodie, B. (2004). Effect of intensive compared with moderate lipid lowering therapy on progression of coronary atherosclerosis. J. of the Ame.Med. Assoc., 291(9), 1071-1080. https://doi.org/10.1001/jama.291.9.1071
- Ojiakor, A., & Nwanjo, H. (2005). Effect of vitamine E and C on exercise induced oxidative stress. Global J. of Pure Applied Sci., 12(2), 199-202.
- Oluyemi, K.A., Omotuyi, I.O., Jimoh, O.R., Adesanya, O.A., Saalu, C.L., & Josiah, S.J. (2007). Erythropoietic and anti-obesity effects of Garcinia cambogia (bitter kola) in Wistar rats. Biotechnol. Appl. Bioc., 46, 69-72. https://doi.org/10.1042/BA20060105
- Poss, J., Custodis, F., Werner, C. & Laufs, U. (2011). Cardiovascular disease and dyslipidemia: Beyond LDL. Curr. Pharmaceu. Design., 17(9), 861-870. https://doi.org/10.2174/138161211795428858
- Quideau, S., Deffieux, D., Douat‐Casassus, C., & Pouysegu, L. (2011). Plant polyphenols: chemical properties, biological activities, and synthesis. Angewandte Chemie International Edition, 50(3), 586-621. https://doi.org/10.1002/anie.201000044
- Rohman, A., Riyanto, S., Yuniarti, N., Saputra, W.R., Utami, R., & Mulatsih, W. (2010). Antioxidant activity, total phenolic, and total flavaonoid of extractsand fractions of red fruit (Pandanus conoideus Lam). Internat. Food Res. J., 17, 97-106.
- Saravanan, N., Rajendra, P., & Pugalandi, K.V. (2003). Effect of Piper betle leaf extract on alcoholic toxicity in the rat brain. J.Med.Food, 6, 261-265. https://doi.org/10.1089/10966200360716689
- Sikarwar, M.S., & Patil, M.B. (2011). Antihyperlipidemic Effect of Ethanolic Extract of Hibiscus rosa sinensis Flowers in Hyperlipidemic Rats. RGUHS J. of Pharmaceu. Sci., 1(2), 117-122.
- Sofowora, E.A. (1993). Medicinal plants and traditional medicine in Africa. Chicago, IL: University of Illinois.
- Stein, E.A. (1987). Lipids, lipoproteins and apolipoproteins. In N.W. Tietz, Textbook of Clinical Chemistry (pp. 829-900). Philadelphia, PA: Saunders.
- Steinleitner, A., Lambert, H., Kazensky, C., & Cantor, B. (1991). Poloxamer-407 as an intraperitoneal barrier material for the prevention of postsurgical adhesion formation and reformation in rodent models for reproductive surgery. Obstet. Gynecol., 77, 48-52.
- Vaziri, N.D., & Morris, K. (2011). Lipid disorders and their relevance to outcomes in chronic kidney disease. Blood Purification, 31(1-3), 189-196. https://doi.org/10.1159/000321845
- Yokozawa, T., Cho, E.J., & Sasaki, S. (2006). The protective role of Chinese prescription kangen-karyu extract on diet- induced hypercholesterolemia in rats. Biological and Pharmaceutical Bulletin, 29, 760-765. https://doi.org/10.1248/bpb.29.760